Stock Market Today
Wyatt Research Week in Review: Nov. 15-21
It was a red letter day for IPOs on Thursday, with two high-profile offerings finishing solidly in the green when the dust settled on the trading floor. Read more
Wyatt Research Week in Review: Nov. 8-14
In investing, as in life, you win some, you lose some. Nobody’s infallible. But it’s always nice when we accurately predict the future. Read more
Is an Interest Rate Hike All But Guaranteed in 2015?
The Labor Department released a solid jobs report last Friday, with non-farm payrolls rising by 271,000. Does this spell a December interest rate hike? Read more
Wyatt Research Week in Review: Nov. 1-7
The Valeant Pharmaceuticals soap opera was running again this week, with an investing legend making a cameo appearance in the melodrama. Read more
Is the October Market Rally Sustainable?
The worst third quarter in four years was followed by a blowout market rally in October. Read more
Wyatt Research Week in Review: Oct. 25-31
It’s official: 2015 is the year of the merger. Read more
Wyatt Research Week in Review: Oct. 18-24
It was a rough week for Bill Ackman, the world’s leading champion of Valeant Pharmaceuticals International. Read more
Wyatt Research Week in Review: Oct. 11-17
With the next Fed policy meeting looming on Oct. 27-28, the rate hike chatter has begun anew. But this time, global economists have joined the clamor. Read more
Wyatt Research Week in Review: Oct. 4-10
Trouble is brewing for the proposed mega-merger between Anheuser-Busch InBev NV and SABMiller PLC, the world’s No. 1 and No. 2 beer companies. Read more